Publication Information

{'id': 'https://openalex.org/W2362759457', 'doi': None, 'title': 'Analysis of therapeutic effects of 284 patients with ulcerative colitis', 'display_name': 'Analysis of therapeutic effects of 284 patients with ulcerative colitis', 'publication_year': 2015, 'publication_date': '2015-01-01', 'ids': {'openalex': 'https://openalex.org/W2362759457', 'mag': '2362759457'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTotal-DLYK201505021.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2765053249', 'display_name': 'Dalian Yike Daxue xuebao', 'issn_l': '1671-7295', 'issn': ['1671-7295'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4328141921', 'host_organization_name': 'Dalian Medical University', 'host_organization_lineage': ['https://openalex.org/P4328141921'], 'host_organization_lineage_names': ['Dalian Medical University'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5100932597', 'display_name': 'Linglin Tian', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140813', 'display_name': 'First Affiliated Hospital of Dalian Medical University', 'ror': 'https://ror.org/055w74b96', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210140813']}, {'id': 'https://openalex.org/I191996457', 'display_name': 'Dalian Medical University', 'ror': 'https://ror.org/04c8eg608', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I191996457']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Tian Ling-lin', 'raw_affiliation_strings': ['Department of Gastroenterology,the First Affiliated Hospital of Dalian Medical University'], 'affiliations': [{'raw_affiliation_string': 'Department of Gastroenterology,the First Affiliated Hospital of Dalian Medical University', 'institution_ids': ['https://openalex.org/I4210140813', 'https://openalex.org/I191996457']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5100932597'], 'corresponding_institution_ids': ['https://openalex.org/I4210140813', 'https://openalex.org/I191996457'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 66}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.9985, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.9985, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T14331', 'display_name': 'Medicinal Plant Pharmacodynamics Research', 'score': 0.9875, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11503', 'display_name': 'Cytokine Signaling Pathways and Interactions', 'score': 0.987, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/mesalazine', 'display_name': 'Mesalazine', 'score': 0.99036884}, {'id': 'https://openalex.org/keywords/enema', 'display_name': 'Enema', 'score': 0.8179749}, {'id': 'https://openalex.org/keywords/suppository', 'display_name': 'Suppository', 'score': 0.80769587}, {'id': 'https://openalex.org/keywords/sulfasalazine', 'display_name': 'Sulfasalazine', 'score': 0.5935154}], 'concepts': [{'id': 'https://openalex.org/C2779174533', 'wikidata': 'https://www.wikidata.org/wiki/Q412479', 'display_name': 'Mesalazine', 'level': 4, 'score': 0.99036884}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9006816}, {'id': 'https://openalex.org/C2776530707', 'wikidata': 'https://www.wikidata.org/wiki/Q194517', 'display_name': 'Enema', 'level': 2, 'score': 0.8179749}, {'id': 'https://openalex.org/C2778042862', 'wikidata': 'https://www.wikidata.org/wiki/Q180799', 'display_name': 'Suppository', 'level': 2, 'score': 0.80769587}, {'id': 'https://openalex.org/C2780479503', 'wikidata': 'https://www.wikidata.org/wiki/Q1477', 'display_name': 'Ulcerative colitis', 'level': 3, 'score': 0.7774433}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.702946}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.64315575}, {'id': 'https://openalex.org/C2779383735', 'wikidata': 'https://www.wikidata.org/wiki/Q420035', 'display_name': 'Sulfasalazine', 'level': 4, 'score': 0.5935154}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.5398298}, {'id': 'https://openalex.org/C2777056448', 'wikidata': 'https://www.wikidata.org/wiki/Q285166', 'display_name': 'Oral administration', 'level': 2, 'score': 0.44186}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.23618644}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTotal-DLYK201505021.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2765053249', 'display_name': 'Dalian Yike Daxue xuebao', 'issn_l': '1671-7295', 'issn': ['1671-7295'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4328141921', 'host_organization_name': 'Dalian Medical University', 'host_organization_lineage': ['https://openalex.org/P4328141921'], 'host_organization_lineage_names': ['Dalian Medical University'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.8, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2784220241', 'https://openalex.org/W2614583537', 'https://openalex.org/W2392725485', 'https://openalex.org/W2385800859', 'https://openalex.org/W2379441256', 'https://openalex.org/W2377486882', 'https://openalex.org/W2358123938', 'https://openalex.org/W2356228590', 'https://openalex.org/W2355129079', 'https://openalex.org/W2353019440', 'https://openalex.org/W2352254143', 'https://openalex.org/W2350497213', 'https://openalex.org/W2349558415', 'https://openalex.org/W2347223478', 'https://openalex.org/W2154052814', 'https://openalex.org/W2123129494', 'https://openalex.org/W2085520559', 'https://openalex.org/W2078905380', 'https://openalex.org/W1996348098', 'https://openalex.org/W1990013125'], 'abstract_inverted_index': {'Objective': [0], 'To': [1], 'analyze': [2], 'the': [3, 25, 30, 150, 239], 'clinical': [4], 'efficacy': [5], 'of': [6, 11, 27, 34, 106, 114, 201, 212, 260, 277], 'different': [7, 52, 110], 'medication': [8, 111], 'and': [9, 83, 99, 112, 207, 218, 224, 266], 'routes': [10, 113], 'administration': [12, 115], 'on': [13], 'ulcerative': [14, 192], 'colitis(': [15, 193], 'UC)': [16], 'patients.': [17], 'Methods': [18], '284': [19], 'UC': [20], 'patients,who': [21], 'were': [22, 60, 116], 'admitted': [23], 'to': [24, 42, 51, 203, 262], 'Department': [26], 'Gastroenterology': [28], 'at': [29], 'First': [31], 'Affiliated': [32], 'Hospital': [33], 'Dalian': [35], 'Medical': [36], 'University': [37], 'from': [38], '1.': [39, 40, 43, 44], '2010': [41], '2015,were': [45], 'included': [46], 'in': [47], 'this': [48], 'study.': [49], 'According': [50], 'regimens,patients': [53], 'with': [54, 190, 198, 257], 'mild-to-moderate': [55, 130, 230], 'severity': [56, 59], 'or': [57], 'moderate-to-severe': [58, 176, 249], 'divided': [61], 'into': [62], '6': [63], 'groups:': [64], 'Sulfasalazine(': [65], 'SASP)': [66], 'group,Mesalazine': [67], 'group,oral': [68, 75], 'Mesalazine': [69, 71, 76, 143, 145, 162, 232, 234], '+': [70, 124, 144, 163, 233], 'enema': [72, 79, 102, 146, 165, 235], '/': [73, 96, 103, 147, 205, 236, 264], 'suppository': [74, 148, 237], '+Glucosteroids(': [77], 'GCS)': [78], 'group,intravenous': [80], 'GCS': [81, 247], 'group': [82], 'Infliximab(': [84], 'IFX)': [85], 'group.': [86], 'Administration': [87], 'methods': [88], 'can': [89, 195, 254], 'be': [90, 196, 255], 'summarized': [91], 'as': [92], 'systemic': [93], 'application(': [94], 'oral': [95, 142, 156, 161], 'intravenous': [97], 'dosage)': [98], 'topical': [100], 'usage(': [101], 'suppository).': [104], 'Comparison': [105], 'therapeutic': [107], 'effects': [108], 'between': [109], 'conducted.': [117], 'Overall': [118], 'response': [119], 'rate(': [120], 'ORR)': [121], '=remission': [122], 'rate': [123], 'effective': [125], 'rate.': [126], 'Results(': [127], '1)': [128, 228], 'For': [129, 175, 229], 'cases,Mesalazine': [131], 'was': [132, 149, 166, 178, 220], 'better': [133, 179, 245], 'than': [134, 180, 246], 'SASP(': [135], '92.': [136, 158], '06%,vs.': [137], '68.': [138], '18%,P': [139], '0.': [140, 172, 186], '01);': [141], 'best': [151, 240], 'regimen(': [152], '95.': [153], '16%),followed': [154], 'by': [155], 'Mesalazine(': [157], '06%);': [159], 'while': [160], 'GSC': [164], 'found': [167], 'least': [168], 'effective(': [169], '90.': [170, 184], '63%),P': [171], '05.(': [173], '2)': [174, 242], 'cases,IFX': [177], 'GCS(': [181], '100%': [182], 'vs.': [183], '63%,P': [185], '05).(': [187], '3)': [188, 251], 'Patients': [189], 'refractory': [191], 'RUC)': [194], 'rescued': [197], 'longer': [199, 258], 'duration': [200, 259], 'GCS,transition': [202, 261], 'immunosuppressants': [204, 263], 'biologicals': [206, 265], 'surgery.(': [208, 267], '4)': [209, 268], 'Safety:': [210], 'Incidence': [211], 'adverse': [213], 'events(': [214], 'AEs)': [215], 'for': [216, 248], 'SASP,Mesalazine': [217], 'IFX': [219, 243], '27.': [221], '27%,2.': [222], '13%': [223], '6.': [225], '67%,respectively.': [226], 'Conclusion(': [227], 'cases,oral': [231], 'is': [238, 244, 271], 'regimen.(': [241], 'cases.(': [250], 'RUC': [252], 'patients': [253], 'managed': [256], 'Drug': [269], 'therapy': [270], 'relatively': [272], 'safe,and': [273], 'has': [274], 'low': [275], 'incidence': [276], 'AEs.': [278]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2362759457', 'counts_by_year': [], 'updated_date': '2024-12-15T14:39:48.800489', 'created_date': '2016-06-24'}